| GO process |
|
|
| GO:0006355: regulation of transcription, DNA-dependent (BP) |
3.34324E-13 |
39 |
| GO:0007165: signal transduction (BP) |
3.77687E-13 |
42 |
| GO:0045944: positive regulation of transcription from RNA polymerase II promoter (BP) |
1.84064E-11 |
22 |
| GO:0051301: cell division (BP) |
1.13136E-10 |
19 |
| GO:0044419: interspecies interaction between organisms (BP) |
1.67014E-10 |
20 |
| GO:0007049: cell cycle (BP) |
3.92822E-09 |
21 |
| GO:0007399: nervous system development (BP) |
5.35901E-09 |
12 |
| GO:0007156: homophilic cell adhesion (BP) |
8.576E-09 |
8 |
| GO:0030154: cell differentiation (BP) |
1.00415E-08 |
22 |
| GO:0008285: negative regulation of cell proliferation (BP) |
1.15719E-08 |
18 |
| KEGG pathway |
|
|
| Kegg:05200: Pathways in cancer |
1.85246E-11 |
21 |
| Kegg:04722: Neurotrophin signaling pathway |
4.02366E-10 |
13 |
| Kegg:04310: Wnt signaling pathway |
3.9198E-09 |
13 |
| Kegg:04510: Focal adhesion |
1.10106E-07 |
13 |
| Kegg:04115: p53 signaling pathway |
3.36014E-07 |
8 |
| Kegg:04110: Cell cycle |
4.83318E-07 |
10 |
| Kegg:05212: Pancreatic cancer |
5.06487E-07 |
8 |
| Kegg:05220: Chronic myeloid leukemia |
7.02671E-07 |
8 |
| Kegg:04120: Ubiquitin mediated proteolysis |
1.1415E-06 |
10 |
| Kegg:05221: Acute myeloid leukemia |
1.61649E-06 |
7 |
| Panther pathway |
|
|
| Panther:P00057: Wnt signaling pathway |
5.18994E-10 |
18 |
| Panther:P00021: FGF signaling pathway |
1.24487E-08 |
11 |
| Panther:P00053: T cell activation |
8.93741E-08 |
9 |
| Panther:P00010: B cell activation |
2.05044E-06 |
7 |
| Panther:P00012: Cadherin signaling pathway |
4.86842E-06 |
6 |
| Panther:P00031: Inflammation mediated by chemokine and cytokine signaling pathway |
5.58894E-06 |
11 |
| Panther:P00047: PDGF signaling pathway |
9.10927E-06 |
6 |
| Panther:P00013: Cell cycle |
1.13184E-05 |
3 |
| Panther:P00012: Cadherin signaling pathway |
1.16394E-05 |
9 |
| Panther:P00005: Angiogenesis |
0.000016605 |
6 |
